• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prevalence of resistence to activated protein C (APC-resistance) in blood donors in Kosovo.在科索沃的献血者中,抗活化蛋白 C(APC 抵抗)的流行率。
Bosn J Basic Med Sci. 2009 Nov;9(4):329-34. doi: 10.17305/bjbms.2009.2789.
2
Prevalence of factor V Leiden mutation in Yugoslav thrombophilic patients and its relationship to the laboratory diagnosis of APC resistance.南斯拉夫血栓形成倾向患者中凝血因子V莱顿突变的患病率及其与活化蛋白C抵抗实验室诊断的关系。
Thromb Haemost. 2000 Oct;84(4):723-4.
3
High prevalence of factor V Leiden in healthy Jordanian Arabs.健康约旦阿拉伯人中因子V莱顿突变的高患病率。
Thromb Haemost. 1999 Apr;81(4):582-4.
4
[Study of activated protein C resistance(APC-R) and FV Leiden in healthy blood donors and patients with thrombosis].[健康献血者和血栓形成患者中活化蛋白C抵抗(APC-R)及凝血因子V莱顿突变的研究]
Zhonghua Xue Ye Xue Za Zhi. 1998 Sep;19(9):455-7.
5
Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis.韩国深静脉血栓形成患者中活化蛋白C抵抗和凝血因子V Arg506至Gln突变的低患病率。
J Korean Med Sci. 1998 Dec;13(6):587-90. doi: 10.3346/jkms.1998.13.6.587.
6
[Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population].[活化蛋白C抵抗与静脉血栓形成倾向:德国人群的分子遗传学患病率研究]
Dtsch Med Wochenschr. 1999 Jun 25;124(25-26):783-7. doi: 10.1055/s-2007-1024412.
7
Resistance to activated protein C, factor V leiden and the prothrombin G20210A variant in patients with colorectal cancer.结直肠癌患者对活化蛋白C、凝血因子V莱顿突变和凝血酶原G20210A变异体的抵抗情况。
Pathophysiol Haemost Thromb. 2002 Jan-Feb;32(1):2-7. doi: 10.1159/000057282.
8
[APC resistance--most frequent familial thrombophilia].[抗磷脂酶C抵抗——最常见的家族性易栓症]
Ther Umsch. 1999 Sep;56(9):499-501. doi: 10.1024/0040-5930.56.9.499.
9
Hereditary thrombophilia in elite athletes.精英运动员中的遗传性血栓形成倾向
Med Sci Sports Exerc. 2002 Feb;34(2):218-21. doi: 10.1097/00005768-200202000-00006.
10
The association between activated protein C ratio and Factor V Leiden are gender-dependent.活化蛋白 C 比值与因子 V 莱顿之间的关联具有性别依赖性。
Clin Chem Lab Med. 2019 Jul 26;57(8):1229-1234. doi: 10.1515/cclm-2018-1382.

引用本文的文献

1
Vascular Genetic Variants and Ischemic Stroke Susceptibility in Albanians from the Republic of Macedonia.马其顿共和国阿尔巴尼亚族人群中的血管遗传变异与缺血性中风易感性
Open Access Maced J Med Sci. 2016 Dec 15;4(4):556-564. doi: 10.3889/oamjms.2016.114. Epub 2016 Oct 1.
2
Prevalence and role of antithrombin III, protein C and protein S deficiencies and activated protein C resistance in Kosovo women with recurrent pregnancy loss during the first trimester of pregnancy.抗凝血酶III、蛋白C和蛋白S缺乏症以及活化蛋白C抵抗在科索沃妊娠早期复发性流产妇女中的患病率及作用
J Hum Reprod Sci. 2015 Oct-Dec;8(4):224-9. doi: 10.4103/0974-1208.170407.
3
Epidemiology of activated protein C resistance and factor v leiden mutation in the mediterranean region.地中海地区活化蛋白 C 抵抗和因子 V 莱顿突变的流行病学。
Mediterr J Hematol Infect Dis. 2011;3(1):e2011037. doi: 10.4084/MJHID.2011.037. Epub 2011 Sep 8.

本文引用的文献

1
The Prevalence of Activated Protein C Resistance and F V Leiden in Healthy Population of Edirne, Turkey.土耳其埃迪尔内健康人群中活化蛋白C抵抗和F V莱顿突变的患病率
Turk J Haematol. 2002 Jun 5;19(2):287-91.
2
Congenital and acquired activated protein C resistance.先天性和获得性活化蛋白C抵抗
Semin Vasc Med. 2003 Feb;3(1):33-46. doi: 10.1055/s-2003-38331.
3
Factor V Leiden in blood donors in Baghdad (Iraq).伊拉克巴格达献血者中的凝血因子V莱顿突变
Clin Chem. 2004 Mar;50(3):677-8. doi: 10.1373/clinchem.2003.029314.
4
Coagulopathies and arterial stroke.凝血障碍与动脉性卒中
J Neuroophthalmol. 2003 Mar;23(1):63-71. doi: 10.1097/00041327-200303000-00012.
5
Genetic susceptibility to venous thrombosis.静脉血栓形成的遗传易感性。
N Engl J Med. 2001 Apr 19;344(16):1222-31. doi: 10.1056/NEJM200104193441607.
6
Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease.止血基因多态性在静脉和动脉血栓性疾病中的作用。
Blood. 2000 Mar 1;95(5):1517-32.
7
The challenge of thrombophilia in maternal-fetal medicine.母胎医学中血栓形成倾向的挑战。
N Engl J Med. 2000 Feb 10;342(6):424-5. doi: 10.1056/NEJM200002103420610.
8
Prevalence of factor V Leiden in the Chinese population.中国人群中凝血因子V莱顿突变的患病率。
Zhonghua Yi Xue Za Zhi (Taipei). 1999 Dec;62(12):875-8.
9
High prevalence of factor V mutation (Leiden) in the Eastern Mediterranean.东地中海地区因子V突变(莱顿突变)的高流行率。
Clin Chem. 2000 Jan;46(1):134-6.
10
Prevalence of mild hyperhomocysteinaemia and association with thrombophilic genotypes (factor V Leiden and prothrombin G20210A) in Italian patients with venous thromboembolic disease.意大利静脉血栓栓塞性疾病患者中轻度高同型半胱氨酸血症的患病率及其与血栓形成倾向基因型(因子V莱顿突变和凝血酶原G20210A)的关联
Br J Haematol. 1999 Aug;106(2):564-8. doi: 10.1046/j.1365-2141.1999.01613.x.

在科索沃的献血者中,抗活化蛋白 C(APC 抵抗)的流行率。

Prevalence of resistence to activated protein C (APC-resistance) in blood donors in Kosovo.

机构信息

National Blood Transfusion Centre of Kosovo, Prishtina (NBTCK), Mother Theresa Str., 10000 Prishtina, Kosovo.

出版信息

Bosn J Basic Med Sci. 2009 Nov;9(4):329-34. doi: 10.17305/bjbms.2009.2789.

DOI:10.17305/bjbms.2009.2789
PMID:20002000
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5603690/
Abstract

One of the most frequent hereditary causes of thrombophilia is, without a doubt, resistance to Activated Protein C (APC-resistance), which is a consequence of point mutation in gene coding for coagulation Factor V (Factor V Leiden) in 90-95% of cases. The aim of this paper was to determine prevalence of APC-resistance in a group of healthy blood donors. The size of the group is quite representative of Kosovo Albanians. A total of 944 blood donors were examined (537 males and 407 females), for whom APC-resistance was determined by functional methods of coagulation using the kit ACTICLOT(R) Protein C Resistance. Method is based on the test of APTT determined twice: first in the presence and second in the absence of activated Protein C (APC). The ratio of these two values constitutes is called Activated Protein C- Sensitivity Ratio (APC-SR). From 944 examined donors, pathologic values of APC-SR (1,3-1,9) were found in 32 persons (3,4% of the total number). The distribution among sexes was 3,35% (18/537) in male and 3,43% (14/407) in female subjects. The mean values of APC-SR (1,64 in male and 1,71 in female subjects) were not significantly different (P = 0,22). Based on these results, we conclude that the prevalence of APC resistance in Albanian population of Kosovo is within the lower limit of prevalence in general population in different countries of European countries, which, according to some authors ranges is from 3 to 7%.

摘要

最常见的遗传性血栓形成倾向原因之一无疑是活化蛋白 C 抵抗(APC 抵抗),这是凝血因子 V 基因编码(因子 V 莱顿突变)中 90-95%点突变的结果。本文旨在确定 APC 抵抗在一组健康献血者中的流行率。该组的规模在科索沃阿尔巴尼亚人中具有相当的代表性。共检查了 944 名献血者(537 名男性和 407 名女性),通过使用 ACTICLOT(R)蛋白 C 抵抗的凝血功能方法确定 APC 抵抗。该方法基于两次测定 APTT:第一次在存在和第二次在不存在活化蛋白 C(APC)的情况下进行。这两个值的比值称为活化蛋白 C 敏感性比(APC-SR)。在 944 名受检者中,发现 32 人(占总人数的 3.4%)存在 APC-SR(1.3-1.9)的病理值。男女之间的分布分别为 3.35%(18/537)男性和 3.43%(14/407)女性。APC-SR 的平均值(男性为 1.64,女性为 1.71)无显著差异(P=0.22)。基于这些结果,我们得出结论,科索沃阿尔巴尼亚人群中 APC 抵抗的流行率处于欧洲不同国家普通人群流行率的下限范围内,根据一些作者的说法,该范围为 3%至 7%。